Skip to main content
Premium Trial:

Request an Annual Quote

Adarza BioSystems Raises $25 Million in Series D Funding Round

NEW YORK – Biotech company Adarza BioSystems said on Tuesday that it has raised $25 million in a Series D financing round.

The round was co-led by 3x5 Partners and Lightchain Capital. With the closing of the Series D round, Adarza also added Lightchain Managing Director Drew Dennison and 3x5 Partners Managing Director Joe Biller to its board.

Adarza said it will use the funds to support the full commercialization of Ziva, its automated multiplexed biological molecule testing platform for academic and clinical research. Ziva, which is scheduled for commercial launch in June, will allow researchers to identify inflammation, cardiovascular, and oncology protein biomarkers for disease profiling and drug development, the company said.

Adarza's technology includes a benchtop instrument and a portfolio of multiplexed assays that can assess hundreds of protein biomarkers simultaneously from a single biological sample. The company has created arrays of biologically active molecules on silicon chips capable of detecting a wide variety of targets in a single test, including antibodies, nucleic acids, peptides, and whole viruses or bacteria.

The company said St. Louis-based biotech firm Wugen is already using the Ziva platform in its efforts to develop gene-editing technologies to create cell-based treatments for cancer, such as CAR T therapies.

Including the Series D funding, Adarza said it has raised a total of $54 million.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.